about
Novel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanismCross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccineProbing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signalingA rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primatesModified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.Identification of serum biomarkers for canine B-cell lymphoma by use of surface-enhanced laser desorption-ionization time-of-flight mass spectrometry.Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.Recombinant raccoon pox vaccine protects mice against lethal plague.Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever.Ribozymes in gene therapy.Improved accumulation and activity of ribozymes expressed from a tRNA-based RNA polymerase III promoter.Genetic and phenotypic characterization of manufacturing seeds for a tetravalent dengue vaccine (DENVax).Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaquesNovel formulations enhance the thermal stability of live-attenuated flavivirus vaccines.par-2, a gene required for blastomere asymmetry in Caenorhabditis elegans, encodes zinc-finger and ATP-binding motifsSafety and Immunogenicity of a Live Attenuated Tetravalent Dengue Vaccine Candidate in Flavivirus-Naive Adults: A Randomized, Double-Blinded Phase 1 Clinical Trial.CD8+ T-cell Responses in Flavivirus-Naive Individuals Following Immunization with a Live-Attenuated Tetravalent Dengue Vaccine Candidate.Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 studyChikungunya virus and prospects for a vaccine.Deciphering the protective role of adaptive immunity to CHIKV/IRES a novel candidate vaccine against Chikungunya in the A129 mouse model.Protection of black-tailed prairie dogs (Cynomys ludovicianus) against plague after voluntary consumption of baits containing recombinant raccoon poxvirus vaccine.Caenorhabditis elegans DNA that directs segregation in yeast cellsImmunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice.Immunization of black-tailed prairie dog against plague through consumption of vaccine-laden baits.Limited infection upon human exposure to a recombinant raccoon pox vaccine vector.Anti-gene therapy: the use of ribozymes to inhibit gene function.Characterization of cytokine production by the metrial gland and granulated metrial gland cells.Constraining the cell cycle: regulating cell division and differentiation by gene therapy.Raccoon poxvirus as a mucosal vaccine vector for domestic cats.Optimizing the cell efficacy of synthetic ribozymes. Site selection and chemical modifications of ribozymes targeting the proto-oncogene c-myb.A physiological study of functional expression in Escherichia coli of the cloned yeast imidazoleglycerolphosphate dehydratase gene.Intralesional lipid-complexed cytokine/superantigen immunogene therapy for spontaneous canine tumorsStructure and Expression of the Collagen Genes of C. ElegansCentromeric DNA from Saccharomyces cerevisiae
P50
Q21559402-147F1234-7165-455F-90C9-BB0BB79F2CA8Q24276414-5F444803-2827-42DE-A957-C13897C7E8F8Q24608725-49DBB8CF-9332-4015-BAF3-4318B60DC48FQ28241909-09883691-68FA-431A-9CB8-8764702BEE6BQ30366666-9FE41F95-0746-415B-90CE-299CAEF06367Q30426730-76186B30-F444-4EAE-BD7D-5E5808526DEAQ33280637-4A2A6C9A-6B3D-46BA-9776-C1B4BC715950Q33635050-87DD72E5-7D64-4064-B06D-0C24E0D9444BQ34174062-9AF6474A-8226-4B69-874A-A5BB3336DFB0Q34202440-C753DAC6-3E3D-434F-8A78-E3BE9CD07F44Q34297398-02F21CC9-559C-4CF8-8D5A-2DFB68559668Q34757765-A798671C-A1B2-4D59-9A61-217A3D62DB35Q34759091-E2CF81EE-3F99-4124-B405-BCC7C2067918Q35031833-A16D27F5-E556-43F9-9910-D4CEBBC8B3ECQ35269464-B8C0C2B0-9A61-4F06-B30A-10C9C6E0B833Q35553959-5A4F9F16-3E31-4AC9-B60C-1E13AF02CB1AQ36024479-D25468C5-50C5-46F5-A1CB-58A0ACD96DEAQ36208591-C21B6000-4141-4D19-980C-EF0592C04513Q36288109-2D2C05BE-59CF-4BF1-94BF-D0F464B744DEQ36582816-420544BA-30DB-46AB-92DB-EF451904C1F4Q37065242-15CD5600-B32E-429C-818C-99F594F9D692Q37521877-8D861F69-D811-49BE-B557-147C7C8792C4Q37692040-E12807D7-591C-4AC3-8444-253D12FEEA80Q40302299-79BFFBA4-681A-4BDB-A66F-2AE1D16680A1Q41441423-B3DC2709-74DB-47B6-903C-98074AE59081Q41462043-6BA2FA92-03D0-4E8F-97D8-187A90EB098DQ41563534-653C52CA-1BCB-4DAC-B3D7-DFFBAC018680Q41696351-382ACF99-71D1-4088-9CE0-E0328749063DQ45865952-366151EB-42DE-4CE1-9617-C714BE735B41Q47326782-BFBC42E7-1D75-4DFD-A180-F245B0160191Q48057859-9461490C-61A1-44BC-8EE8-FD080A9F6A09Q54558966-C3401E3A-D5B5-4DCE-8370-B4BEF140EDAEQ56880175-D09EE407-BE82-4D1B-949F-9F719DC0DD30Q56880177-AA0C4BA3-5111-41AC-BCE1-FB914AABF355Q56880178-7DEFDDB3-01BF-4BFF-94C3-EBA86D6AAF0A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dan T Stinchcomb
@ast
Dan T Stinchcomb
@en
Dan T Stinchcomb
@es
Dan T Stinchcomb
@nl
Dan T Stinchcomb
@sl
type
label
Dan T Stinchcomb
@ast
Dan T Stinchcomb
@en
Dan T Stinchcomb
@es
Dan T Stinchcomb
@nl
Dan T Stinchcomb
@sl
prefLabel
Dan T Stinchcomb
@ast
Dan T Stinchcomb
@en
Dan T Stinchcomb
@es
Dan T Stinchcomb
@nl
Dan T Stinchcomb
@sl
P106
P21
P31
P496
0000-0002-3634-7503